Markets:

Overview

News

Currencies

International

Treasuries

West Pharmaceutical Services, Inc. Common Stock (NY:WST)

382.20 +7.55 (+2.01%)

Delayed Quote Updated: 2:33 PM EDT, Oct 15, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about West Pharmaceutical Services, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

15 16 Next >

1 Cash-Producing Stock on Our Buy List and 2 Facing Challenges

October 05, 2026

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Luc...

Via StockStory

Topics Economy Firearms

Drug Development Inputs & Services Stocks Q2 Highlights: West Pharmaceutical Services (NYSE:WST)

September 30, 2026

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ...

Via StockStory

Topics Economy

1 S&P 500 Stock with Exciting Potential and 2 We Ignore

September 22, 2026

While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor exec...

Via StockStory

Topics Economy Stocks

1 Surging Stock with Solid Fundamentals and 2 That Underwhelm

September 21, 2026

The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorab...

Via StockStory

Topics Economy

3 Profitable Stocks with Warning Signs

September 10, 2026

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ...

Via StockStory

Topics Economy Supply Chain

1 of Wall Street’s Favorite Stocks for Long-Term Investors and 2 We Ignore

September 02, 2026

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember...

Via StockStory

Topics Economy

1 Mid-Cap Stock on Our Buy List and 2 Facing Headwinds

September 01, 2026

Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to beco...

Via StockStory

Topics Economy

1 Healthcare Stock with Exciting Potential and 2 We Avoid

August 27, 2026

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have be...

Via StockStory

Topics Economy

3 Cash-Heavy Stocks We Approach with Caution

July 31, 2026

Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they strugg...

Via StockStory

Topics Economy

3 Reasons to Avoid WST and 1 Stock to Buy Instead

July 31, 2026

West Pharmaceutical Services has been on fire lately. In the past six months alone, the company’s stock price has rocketed 43%, reaching $339.52 per share. T...

Via StockStory

The 5 Most Interesting Analyst Questions From West Pharmaceutical Services’s Q2 Earnings Call

July 30, 2026

West Pharmaceutical Services posted a solid Q2, with revenue and adjusted earnings per share exceeding Wall Street expectations, while the market response re...

Via StockStory

Topics Earnings

Uncover the latest developments among S&P500 stocks in today's session. ↗

July 24, 2026

Via Chartmill

Hims & Hers Health, Repligen, West Pharmaceutical Services, and 10x Genomics Stocks Trade Down, What You Need To Know

July 24, 2026

What Happened? A number of stocks fell in the morning session after concerns grew over a rising number of uninsured patients. The trend was highlighted in HC...

Via StockStory

WST Q2 Deep Dive: Biologics and High-Value Components Drive Upgraded Outlook

July 24, 2026

Healthcare products company West Pharmaceutical Services (NYSE:WST) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 13....

Via StockStory

West Pharmaceutical Services Q2 Earnings Call Highlights ↗

July 23, 2026

West Pharmaceutical Services (NYSE:WST) raised its full-year 2026 outlook after reporting second-quarter results that topped management’s expectations, supported by strong demand for high-value product...

Via MarketBeat

Topics Earnings

Full Transcript: West Pharmaceutical Servs Q2 2026 Earnings Call ↗

July 23, 2026

West Pharmaceutical Servs (NYSE:WST) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. Benzinga APIs provide...

Via Benzinga

Topics Earnings

These S&P500 stocks that are showing activity before the opening bell on Thursday. ↗

July 23, 2026

Via Chartmill

West Pharmaceutical Services (NYSE:WST) Beats Expectations in Strong Q2 CY2026, Stock Soars

July 23, 2026

Healthcare products company West Pharmaceutical Services (NYSE:WST) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 13.8%...

Via StockStory

Topics Economy

West Pharmaceutical Services (WST) Q2 Earnings Report Preview: What To Look For

July 22, 2026

Healthcare products company West Pharmaceutical Services (NYSE:WST) will be announcing earnings results tomorrow before market open. Here’s what to expect. W...

Via StockStory

Topics Artificial Intelligence

3 Reasons WST is Risky and 1 Stock to Buy Instead

July 13, 2026

Over the past six months, West Pharmaceutical Services has been a great trade, beating the S&P 500 by 21.8%. Its stock price has climbed to $353.68, represen...

Via StockStory

Topics Stocks

Life Sciences Tools & Services Stocks Q1 Results: Benchmarking 10x Genomics (NASDAQ:TXG)

July 07, 2026

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ...

Via StockStory

Topics Artificial Intelligence Economy

Life Sciences Tools & Services Stocks Q1 Results: Benchmarking Illumina (NASDAQ:ILMN)

July 06, 2026

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ...

Via StockStory

Topics Artificial Intelligence Economy

1 High-Flying Stock Worth Your Attention and 2 Facing Challenges

June 25, 2026

“You get what you pay for” often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the ...

Via StockStory

Topics Economy

1 Cash-Producing Stock with Exciting Potential and 2 We Brush Off

June 24, 2026

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...

Via StockStory

Topics Economy

Top S&P500 movers in Tuesday's session ↗

June 09, 2026

Via Chartmill

Stay updated with the S&P500 stocks that are on the move in today's pre-market session. ↗

June 09, 2026

Via Chartmill

Q1 Rundown: UFP Technologies (NASDAQ:UFPT) Vs Other Drug Development Inputs & Services Stocks

June 08, 2026

Wrapping up Q1 earnings, we look at the numbers and key takeaways for the drug development inputs & services stocks, including UFP Technologies (NASDAQ:UFPT)...

Via StockStory

3 Profitable Stocks with Open Questions

June 04, 2026

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...

Via StockStory

Topics Economy

Billionaire Bill Gates' Foundation Dumped Microsoft but Loaded Up on This Dividend Champion ↗

June 02, 2026

The Microsoft founder's foundation recently added this healthcare stock to its portfolio.

Via The Motley Fool

Q1 Earnings Highs And Lows: PacBio (NASDAQ:PACB) Vs The Rest Of The Life Sciences Tools & Services Stocks

June 01, 2026

Looking back on life sciences tools & services stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including PacBio (NASDAQ:PACB) and i...

Via StockStory

Topics Artificial Intelligence Economy

< Previous 1 2 3 4 5 6 7 8 9

...

15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.